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Abstract
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The corneal epithelial tissue is a layer of rapidly growing cells that are highly glycolytic and
express GLUT1 as the major glucose transporter. It has been shown that GLUT1 in L929
fibroblast cells and other cell lines can be acutely activated by a variety agents.However, the acute
regulation of glucose uptake in corneal cells has not been systematically investigated. Therefore,
we examined glucose uptake in an immortalized human corneal–limbal epithelial (HCLE) cell line
and compared it to glucose uptake in L929 fibroblast cells, a cell line where glucose uptake has
been well characterized. We report that the expression of GLUT1 in HCLE cells is 6.6-fold higher
than in L929 fibroblast cells, but the HCLE cells have a 25-fold higher basal rate of glucose
uptake. Treatment with agents that interfere with mitochondrial metabolism, such as sodium azide
and berberine, activate glucose uptake in L929 cells over 3-fold, but have no effect on glucose
uptake HCLE cells. Also, agents known to react with thiols, such cinnamaldehyde, phenyarsine
oxide and nitroxyl stimulate glucose uptake in L929 cells 3 to 4-fold, but actually inhibit glucose
uptake in HCLE cells. These data suggest that in the fast growing HCLE cells, GLUT1 is
expressed at a higher concentration and is already highly activated at basal conditions. These data
support a model for the acute activation of GLUT1 that suggests that the activity of GLUT1 is
enhanced by the formation of an internal disulfide bond within GLUT1 itself.
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1. Introduction
Corneal epithelial cells are rapidly growing cells that have a life cycle of 7-10 days. They
originate from stem cells in the limbal basal region at the edge of the cornea and migrate
across basement membrane of the anterior cornea forming a basal corneal epithelial layer.
Cell division occurs in the basal layer and the daughter cells migrate anteriorly,
differentiating to wing cells and squamous superficial cells that are eventually shed from the
ocular surface, thereby maintaining an epithelium that is 5-7 cell layers thick [1]. Corneal
epithelial cells are reported to have few mitochondria and are known to be heavily
dependent on glycolysis. The predominant or only glucose transporter responsible for
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glucose uptake by corneal epithelial cells is GLUT1 [2-5]. GLUT1 expression and glucose
uptake are enhanced during the corneal epithelial wound healing process, but little else is
known about the regulation of GLUT1 activity [4, 6]. While GLUT1 is responsible for a
basal level of glucose uptake in a wide variety of cells, data from cells that exclusively or
predominately express GLUT1 reveal that this transporter can be acutely activated, that is,
activated within 15 minutes, independent of new GLUT1 biosynthesis. Conditions such as
glucose deprivation [7, 8], hyperposmolarity[9, 10] or exposure to azide[11, 12], methylene
blue [13], C-peptide [14], or berberine[15], and thiol active agents such as
cinnamaldehye[16], phenylarsine oxide [17], and nitroxyl[18] all activate glucose uptake via
GLUT1.
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An immortalized human corneal–limbal epithelial (HCLE) cell line has been developed
[19-21], that forms stratified layers resembling the in vivo corneal epithelium and expresses
the mucins known to be expressed by superficial corneal epithelial cells. We have used these
cells to investigate the protective effects of potassium ions against UVB damage [22, 23].
The HCLE cell line is relatively new and glucose uptake has not been measured, nor has its
response to acute stress been determined. Regulation of glucose uptake in corneal cells is
relevant to diabetic patients where the disease is associated with an increased fragility of the
corneal epithelium and a slowing of wound healing [24-26]. Therefore, the purpose of this
study was to measure glucose uptake in HCLE cells, to confirm the expression of
GLUT1,and to determine if glucose uptake is acutely regulated in a similar fashion to the
regulation of GLUT1 in L929 fibroblast cells [11, 13, 27].The GLUT1 protein is recognized
by the same antibody, which indicates that the transporter is very similar in the two species.
Therefore, this suggests any differences in the regulation of GLUT1 are more likely a
function of different cell types than of different species.

2. Materials and Methods
2.1 Chemicals
Angeli’s salt (AS) was a generous gift of Dr. John P. Toscano (Johns Hopkins University)
and was stored at −4 °C under nitrogen. Phenylarsineoxide (PAO), cinnamaldehyde (CA),
berberine, cytochalasin B, quercetin, 2-deoxy-D-glucose-[1,2-3H] (2DG) and Dmannitol-1-14C were purchased from the Sigma-Aldrich Chemical Company (St. Louis,
MO, USA).
2.2 Cell culture
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The immortalized human corneal–limbal epithelial (HCLE) cell line was obtained from Dr.
Ilene Gipson (Department of Opthalmology, Harvard Medical School) and maintained
asmonolayer cultures in Keratinocyte-Serum Free medium (K-SFM)(Invitrogen, Carlsbad,
CA), as previously described[19]. The L929 mouse fibroblast cells were obtained from the
American Type Culture Collection. To initiate each experiment, a 24-well plate was seeded
either 2 or 3 days (HCLE cells) or 1 day (L929 cells) prior to experimentation. Experiments
were done with cells near confluency, which is about 1.0 × 105cells per well for HCLE cells
and 3.2 × 105for L929 fibroblast cells. The cells were grown at 37 °C in an incubator
supplied with humidified room air with 5% CO2.
2.3 Western Blotting
HCLE or L929 cells from two wells of a 24-well plate were isolated and lysed in 50 μL of
0.5% SDS. The concentration of proteins in the whole cell extract was determined using a
protein assay from Pierce. Proteins (20 μg) were separated on a 12% SDS-PAGE gel.
GLUT1 was detected by Western blotting using a primary anti-GLUT1 rabbit polyclonal
antibody (Millipore, Temecula, CA) and a secondary goat anti-mouse (IRDye™ 800 CW,
Biochimie. Author manuscript; available in PMC 2014 February 01.
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Odyssey). The membrane was imaged with an OdesseyLiCor scanner (Lincoln, NE) and
GLUT1 was quantified using the Odyssey Infrared ImaginingSystem software (version
3.0.25).
2.4 General experimental design
To initiate an experiment, the medium from cells in 24-well plates was removed and the
cells were incubated in 0.8 mL of fresh treatment DMEM media plus glucose and the
chemical of interest at the concentrations indicated. Cells were maintained at 37 °C for 30
minutes. In experiments using AS or PAO there was no treatment phase, but reagents were
added directly to the glucose uptake buffer (see below). In the experiments using AS, the
solid compound was quickly dissolved in uptake medium at room temperature and
immediately applied to the cells in the 24-well plate (process took about 30 seconds). The
cells were then returned to the incubator and the medium was allowed to warm to 37 °C. All
other reagents were added to the media from 100-200x stock aqueous (sodium azide), or
ethanol (cinnamaldehyde, cytochalasin B) or DMSO (berberine, phenylarsine oxide,
quercetin) solutions. Ethanol and DMSO have no effect on glucose uptake at the
concentrations added[16, 17].
2.5 Glucose uptake assay
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Glucose uptake was measured using the radiolabeled glucose analog 2-deoxyglucose (2DG)
as previously described [28]. Briefly, the medium was replaced with 0.4 mL of glucose-free
HEPES buffer (140 mMNaCl, 5 mMKCl, 20 mM HEPES/Na pH=7.4, 2.5 mM MgSO4, 1
mM CaCl2, 2 mM pyruvate, 1 mMmannitol) supplemented with 1.0 mM (0.3 μCi/mL) 2DG (1,2-3H) and 1.0 mM (0.02 μCi/mL) mannitol (1-14C) at 37 °C. Uptake medium was
supplemented with additional compounds, such as AS or PAO, as indicated in the figure
legends. After a 10-minute incubation, cells were washed twice with cold glucose-free
HEPES. The cells were lysed in 0.5 mL lysis buffer (10 mMTris pH=7.4, 150 mMNaCl, 5
mM EDTA, 1.0% triton X-100, 0.4% SDS) and the 3H-2 DG uptake with 14C-mannitol was
measured using scintillation spectrometry. Mannitol is not taken up by these cells, so the
uptake of 14C-mannitol only occurs if there is non-specific cell surface binding or the cell
membrane is compromised by the treatment conditions.
2.6 Data reporting and statistical analysis
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Experimental conditions were repeated in triplicate or quadruplicate and glucose uptake was
measured as nmol/10 min/well ±standard error. Uptakes reported in Figure 1 were expressed
as uptakes per 105 cells. In the remaining figures, data from several experiments were each
normalized to basal conditions, combined and reported as relative 2DG uptake. Data
reported represent the mean from 12-24 samples. Statistical significance was determined by
either ANOVA followed by a post-hoc Dunnett test or a two-tailed t-test. Experiments were
repeated 3-5 times and results from a representative experimentor normalized data from
multiple experiments are reported.

3. Results
3.1 HCLE cells have higher basal glucose uptake rates and expression of GLUT1
The major glucose transporter in corneal epithelial cells is GLUT1. We initially measured
glucose uptake in HCLE cells under basal conditions and the results are shown in Figure 1A.
The 2DG uptake expressed per 105 cells is 25 times greater in HCLE cells than in L929
fibroblast cells. The higher glucose uptake rate in HCLE cells could simply be attributed to
agreater expression of GLUT1, so we quantified the GLUT1 protein in both cell lines.
TheWestern blot analysis of whole cell extracts from L929 and HCLE cells revealed a single
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band for GLUT 1 just below 55 kD, which is shown in Figure 1B. The quantitative analysis
of the GLUT1 band indicates that the expression of GLUT1 is 6.6-fold higher in HCLE cells
than in L929 fibroblast cells. The 6.6-fold increased expression in HCLE cells is not
sufficient to fully account for the 25-fold increase in the basal glucose uptake. Either
GLUT1 is in a higher active state in HCLE cells or other glucose transporters, not yet
documented, are responsible for the additional uptake rate. To ascertain the involvement of
GLUT1, we measured the glucose uptake in both cells lines in the presence of maximally
effective concentrations of cytochalasin B, an inhibitor of the GLUT family of proteins,
orquercetin, a known competitive inhibitor of GLUT1 [29]. The results from each cell line
were normalized to control and are shown on Table 1. The inhibition of glucose uptake was
virtually identical in both cell lines with cytochalasin B reduceduptakes to8% and 9% in
HCLE and L929 cells respectively and quercetin reduced uptakes to 29% and 27%. This
result suggests that the uptake activity we are measuring can be attributed to GLUT1 and it
suggests that some of the 25-fold higher glucose uptake rate is due to increased activity of
GLUT 1. Therefore, we wanted to look more closely at the acute activation of GLUT1 in
HCLE cells.
3.2 Glucose uptake in HCLE cells is activated by glucose deprivation
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We have previously shown that glucose uptake in L929 cells is activated up to 20-fold by a
brief, prior exposure to media with reduced glucose concentrations [7]. We were interested
to determine if glucose uptake by HCLE cells is also sensitive to a brief glucose deprivation
period. HCLE cells in a 24-well plate were exposed to media containing various
concentrations of glucose for 20 minutes prior to measurement of glucose uptake. The
results shown in Figure 2 indicate that there is not a strong dependence of glucose uptake on
prior exposure to glucose. Complete deprivation does significantly activate glucose uptake
by 1.47 times, but there was no difference if the 20-minute treatment phase contained 5.5,
10, 15, 20 or 25 mM glucose.
3.3 Cell stressors do not activate glucose uptake in HCLE cells
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Stressors that have been reported to inhibit mitochondrial function, such as sodium azide
and berberine, have been shown to increase the activity of GLUT1 in L929 cells [15, 18].
We measured the effects of 5.0 mMazide and 50 μM berberine on glucose uptake in HCLE
cells, which are maximally effective concentrations in L929 cells. The results are shown in
Figure 3 with data from L929 cells also shown for comparison. Data sets from L929 and
HCLE cells are each normalized to their respective basal uptakes. In sharp contrast to L929
cells, where both azide and berberine stimulated glucose uptake 3.2-fold, these agents had
no effect on glucose uptake in HCLE cells. Doubling the concentrations of azide and
berberine also had no effect (data not shown).
3.4Thiol active compounds inhibit glucose uptake in HCLE cells
We have shown that a brief treatment with thiol active compounds, such as cinnamaldehyde,
phenylarsine oxide, and nitroxyl, via treatment with Angeli’s salt, all activate glucose uptake
in L929 fibroblast cells [16-18]. The data from these studies and others suggest that GLUT1
can be activated by the formation of a disulfide bond within GLUT1. We tested the effects
of 2 mM CA, 10 μM PAO and 5 mM AS, all maximally effective concentrations in L929
cells, on glucose uptake in HCLE cells. The results are shown in Figure 4 along with data
from L929 cells each normalized to its respective basal uptake. In L929 fibroblast cells,
glucose uptake was significantly increased 3.5-fold by CA, 3.9-fold by PAO, and 4.2-fold
by AS, whereas in HCLE cells uptake was significantly decreased upon exposure to CA and
AS, 0.41 and 0.58 of control respectively (P < 0.01), and slightly reduced by PAO to 0.79 of
control, but the difference was not statistically significant (P < 0.07).
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Corneal epithelial cells rely heavily on glucose uptake via GLUT1 and glucose metabolism
to support their rapid growth [2-6]. In spite of the importance of glucose to corneal epithelial
cell maintenance, there are no systematic studies investigating the regulation of glucose
uptake in these cells. GLUT1 is widely expressed and it is generally thought that this
transporter only responsible for basal glucose uptake. However, recent data from studies in a
number of cells lines where GLUT1 is either the only or the predominant glucose transporter
have demonstrated that this transporter can be acutely activated by number of reagents or
environmental conditions [7-13, 15-18, 30].
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In this study, we have investigated the glucose transport activity in a transformed human
corneal–limbal epithelial cell line. HCLE cells have a 6.6 higher concentration of GLUT1
than L929 cells but have over a 25-fold higher basal rate of glucose uptake (see Figure 1).
This discrepancy suggests that either there is either another glucose transporter at play in
HCLE cells, or that GLUT1 in HCLE cells is in a more active state. However, it does not
seem likely that another glucose transporter is involved. While glucose transporters
expression in HCLE cells has not been systematically measured, a survey of the literature
reveals that only GLUT1 expression has been documented in corneal cells. In addition, the
observation that cytochalasin B, an inhibitor of the GLUT family of transporters, and
quercetin, a competitive inhibitor of GLUT1, identically inhibit uptake in HCLE cells and
L929 cells, a cell line where expression of only GLUT1 has been documented [27], strongly
suggests that we are also measuring GLUT1 activity in HCLE cells (see Table 1).Therefore,
we suggest that the 25-fold higher rate of glucose uptake in HCLE cells is a result of higher
expression and higher activity of GLUT1. This is supported by the relative inability to
activate glucose uptake in HCLE cells. Glucose deprivation only slightly activates glucose
uptake in HCLE cells (1.5-fold, see Figure 2) compared to a robust 10-20-fold activation
observed in L929 cells [7]. Berberine and sodium azide are compounds that activate glucose
uptake via interference with mitochondrial function and possible activation of AMP kinase
[11, 12, 15, 18, 30-32]. These agents activate glucose uptake over 3-foldin L929 cells, but
they have no effect on glucose uptake in HCLE cells (see Figure 3). Given the high
glycolytic dependence and the reported low number of mitochondria in corneal epithelial
cells, it may not be surprising that agents that stress mitochondrial function do not activate
glucose uptake in this cell line. However, thiol reactive agents, which are not known to
affect mitochondrial function, acutely activate glucose uptake in L929 cells, but
inhibituptake in HCLE cells. In L929 cells, CA and AS stimulate glucose uptake 3.5-fold
and 4.2-fold respectively, but reduce uptake by 58%and 42% respectively in HCLE cells.
PAO stimulates uptake 3.9-fold in L929 cells but has no effect in HCLE cells (see Figure 4).
It should benoted that the 3- to 4-fold activation by the wide variety of activators in L929
cells coupled to the 6.6-fold higher expression of GLUT1 in HCLE cells nicely accounts for
the 25-fold difference observed in the two cell lines.
The high concentration and high intrinsic activity of GLUT1 in HCLE cells suggest a
plausible explanation for the observations that the corneal epithelium from diabetic patients
are more fragile and have slower wound healing [24-26]. The high glucose uptake rates via
GLUT1 coupled with high blood glucose concentrations in diabetic patients would produce
higher intracellular concentrations of glucose. This would be expected to increase the
production of intracellular advanced glycationend-products and thereby compromise cell
function [33].
The inhibition of glucose uptake by CA and AS is consistent with a proposed mechanism for
the acute activation of GLUT1 based on data from erythrocytes and L929 cells [34-36]. This
model, shown in Figure 5, suggests that GLUT1 can exist in multiple states ranging from
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low activity monomers, containing reduced cysteine residues, to high activity oligomers,
likely tetramers. The more active tetramer is a noncovalent complex that is stabilized by the
conformation change that occurs when an internal disulfide bond forms within GLUT1.If the
bulk of the GLUT1 transporters in HCLE cells are in a highly activated state, that is,
tetramers with oxidized cysteine residues, the model predicts, as we observe, that reagents
that react with thiols would stabilize a less active form of GLUT1 and shift the overall
equilibrium away from the highly active state. Unfortunately, the denaturing conditions of
SDS electrophoresis prevent the detection of a noncovalenthomotetramer of GLUT1 by
Western blotting. Therefore, additional studies, beyond the scope of this study,are needed to
confirm the formation of a tetramer.
It is interesting to note that the characteristics of fast growth rate, high expression of
GLUT1, and a heavy dependence on glycolysis in corneal epithelial cells are also
characteristics of cancer cells. There is accumulating evidence that many types of cancer
overexpress GLUT1 and have high glucose uptake and glycolytic activity [37-43]. GLUT1
has been identified as a potential anticancer target [37, 44]. The observation that thiol
reactive compounds inhibit glucose uptake in HCLE cells suggests that it may be important
to determine thiol reactive compounds have efficacy as anticancer agents.

5. Conclusions
NIH-PA Author Manuscript

This study demonstrates that corneal epithelial cells have high glucose uptake rates due to
both high expression and high intrinsic activity of GLUT1. In contrast to L929 cells, glucose
uptake is only slightly activated by glucose deprivation, not activated by sodium azide,
berberine, or phenylarsine oxide and inhibited by compounds that react with thiols such as
cinnamaldehyde, and nitroxyl. The data reveal that GLUT1 is acutely regulated in different
ways in different tissues. These data are also consistent with a proposed mechanism for
GLUT1 activation that involves the formation of a disulfide bond within GLUT1.
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Research Highlights
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•

Human corneal epithelial cells (HCLE) have very high basal rates of glucose
uptake.

•

HCLE cells have 6.6-fold higher expression of GLUT1 than L929 cells.

•

GLUT1 in HCLE cells has high intrinsic activity and cannot be further
activated.

•

Thiol reactive compounds inhibit rather than activate glucose uptake in HCLE
cells.
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Figure 1.

Comparison of basal 2DG uptake rates and GLUT1 expression of HCLE and L929 cells. A.
2DG uptake in L929 and HCLE cells expressed as nmol/10min/105 cells. B. Proteins (20
μg) from total cell extracts from L929 and HCLE cells were separated by SDS gel
electrophoresis and probed for GLUT1 by Western blotting. This analysis was done three
times and a representative result is shown.
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Figure 2.
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Effects of glucose concentration on 2DG uptake by HCLE cells. Cells were incubated in
DMEM medium containing 0, 5.5, 10, 15, 20, or 25 mM glucose for 30 minutes. 2DG
uptake data are means ± S.E normalized to uptake at 10 mM glucose for 8-16 samples.
*Significantly different from all other data at P < 0.01.
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Figure 3.

Comparative effects of berberine and sodium azide on 2DG uptake in HCLE and L929 cells.
HCLE and L929 cells were exposed to either 50 μM berberine or 5.0 mM sodium azide for
30 minutes. Data are means ± S.E for 8-12 samples with each cell line normalize to its
respective basal uptakes. *Significantly different from respective basal uptake at P < 0.01.
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Figure 4.

Comparative effects of CA, PAO, and AS on 2DG uptake in HCLE and L929 cells. HCLE
and L929 cells were exposed to either 2.0 mMcinnamaldehyde (CA) for 30 minutes prior to
the measurement of 2DG uptake or exposed to either or 10 μM PAO or 5 mM AS during
uptake. 2DG uptakes rates are means ± S.E for 8-12 samples with each cell line normalized
to its respective uptake under basal or untreated conditions. *Significantly different from
respective basal uptake at P < 0.01.
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Figure 5.

Mechanism for activation of GLUT1. This model for activation suggests that GLUT1 exists
in a number of activation states. A fully reduced, monomer form would have the lowest
transport activity, while the oligomer (likely a tetramer), would have the highest activity.
The modified form of GLUT1 (with X attached) may be more active than the lowest state,
but the modification would prevent conversion to the highest active state if the modification
is not readily reversible.
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Table 1

Effects of cytochalasin B and quercetin on glucose uptake
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Cell

Control

Cytochalasin B

Quercetin

HCLE

1.00 ± 0.05

0.08 ± 0.01*

0.29 ± 0.02*

L929

1.00 ± 0.10

0.09 ± 0.01*

0.27 ± 0.07*

2DG uptakes in both HCLE cells and L929 fibroblasts cells were measured in the absence (control) or presence of either 40μM cytochalasin B or
100μM quercetin. Uptakes from quadruplicate samples were normalize to control and reported as fractions ± S.E.

*

Significantly different from control at P<0.01.
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